Universal Vision Biotechnology Co., Ltd. (3218) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Universal Vision Biotechnology Co., Ltd. (3218:TWSE), powered by AI.

Current Price
$134.00
Sector
Healthcare
What is the Universal Vision Biotechnology Co., Ltd. stock price forecast?

Universal Vision Biotechnology Co., Ltd. is currently trading at $134.00. View real-time AI analysis on Alpha Lenz.

What is Universal Vision Biotechnology Co., Ltd. insider trading activity?

View the latest insider trading data for Universal Vision Biotechnology Co., Ltd. on Alpha Lenz.

What is Universal Vision Biotechnology Co., Ltd.'s P/E ratio?

View Universal Vision Biotechnology Co., Ltd.'s valuation metrics on Alpha Lenz.

Universal Vision Biotechnology Co., Ltd.

TWSE · 3218
NT$134.00+1.00(+0.75%)
Ask about Universal Vision Biotechnology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Universal Vision Biotechnology Co., Ltd.'s ROE is 27.3%. Explore profitability and growth together.

Ask for details

Company Overview

Universal Vision Biotechnology Co., Ltd. is a healthcare company specializing in eye care services and optical products. The firm operates a chain of eye care clinics in Taiwan and China, providing comprehensive ophthalmic services, optometric consultations, and hospital management solutions. Its product portfolio includes optical devices, eyeglasses, prescription lenses, sunglasses, and a range of contact lenses addressing myopia, hyperopia, presbyopia, and astigmatism. The company also offers leasing of medical equipment, technical consultancy, and medical cosmetology services such as eye plastic and micro cosmetic surgery. Serving both medical and consumer needs, Universal Vision Biotechnology Co., Ltd. plays a significant role in the region’s healthcare sector, contributing to advancements in vision correction and eye health through its medical operations and optical retail business. Headquartered in Taipei and founded in the early 1990s, it has established itself as a key provider in the medical equipment and healthcare services industry, supporting eye health across a broad demographic spectrum.

SectorHealthcare
IndustryMedical Care Facilities
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$4.20BRevenue
0.00Shares Out
0Employees

Margins

59.05%Gross
45.46%EBITDA
32.76%Operating
32.01%Pre-Tax
25.09%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

6.36%Rev 3Yr
15.41%Rev 5Yr
8.15%Op Inc 3Yr
18.21%Op Inc 5Yr
6.70%Net Inc 3Yr
16.85%Net Inc 5Yr

Returns

17.79%ROA
27.28%ROE
23.12%ROIC

Financial Health

NT$779.24MCash & Cash Equivalents
NT$1.15BNet Debt
46.50%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Universal Vision Biotechnology Co., Ltd. (ticker: 3218) is a company listed on TWSE in the Healthcare sector (Medical Care Facilities).

The current price is 134 with a P/E ratio of -x and P/B of -x.

ROE is 27.28% and operating margin is 32.76%. Annual revenue is $4.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Universal Vision Biotechnology Co., Ltd. (3218) Stock Forecast 2026 $134.00 — Price, Financials & Analyst Targets | Alpha Lenz